Toledo Community Hospital Oncology Program

aka Toledo Community Oncology Program   |   Toledo, OH   |  tcop.info
This organization has not appeared on the IRS Business Master File in a number of months. It may have merged with another organization or ceased operations.
This organization is not registered with the IRS.

Mission

The Toledo Community Oncology Program (TCOP) brings compassionate and gold standard of cancer care to individuals close to home. This non-profit organization, founded in 1986, is one of the original Community Clinical Oncology Programs (CCOP) funded by the National Cancer Institute.

TCOP administers Phase II, Phase III, and Phase IV cancer clinical trials from these research groups: the Alliance For Clinical Trials in Oncology [consists of the North Central Cancer Treatment Group (NCCTG), the American College of Surgeons Oncology Group (ACSOG), and the Cancer and Leukemia Group B (CLGB)], NRG [consists of the National Surgical Adjuvant Breast and Bowel Project (NSAPB), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG)], the Eastern Cooperative Oncology Group (ECOG), SunCoast, and the Cancer Trials Support Unit (CTSU).

Alliance For Clinical Trials in Oncology [consists of the North Central Cancer Treatment Group (NCCTG), Eastern Cooperative Oncology Group (ECOG), Radiation Therapy Oncology Group (RTOG), National Surgical Adjuvant Breast & Bowel Project (NSABP), and Cancer Trials Support Unit (CTSU).

TCOP also administers Phase II, Phase III and Phase IV pharmaceutical sponsored cancer treatment, prevention & control clinical trials.

Ruling year info

1985

Executive Director

Ms. Pamela Shoup

Main address

3232 Central Park West Suite C

Toledo, OH 43617 USA

Show more contact info

Formerly known as

Toledo Community Hospital Oncology Program

EIN

34-1434759

NTEE code info

Health Treatment Facilities (Primarily Outpatient) (E30)

IRS filing requirement

This organization is required to file an IRS Form 990-N.

Sign in or create an account to view Form(s) 990 for 2017, 2016 and 2015.
Register now

Communication

Blog

Programs and results

What we aim to solve

This profile needs more info.

If it is your nonprofit, add a problem overview.

Login and update

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

The Toledo Oncology Program

Enroll patients to cancer treatment, prevention and control trials.

Population(s) Served

TCOP administers Phase II, Phase III, and Phase IV cancer treatment, prevention and control clinical trials from these research groups: the Alliance For Clinical Trials in Oncology [includes the North Central Cancer Treatment Group (NCCTG), the American College of Surgeons Oncology Group (ACSOG), and the Cancer and Leukemia Group B (CLGB)], NRG [which consists of the National Surgical Adjuvant Breast and Bowel Project (NSAPB), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG)], the Eastern Cooperative Oncology Group (ECOG), SunCoast, and the Cancer Trials Support Unit (CTSU).

Population(s) Served

TCOP also administers Phase II, Phase III, and Phase IV Pharmaceutical Cancer Treatment and Control Clinical Trials sponsored by a number of pharmaceutical companies.

Population(s) Served

Where we work

This profile needs more info.

If it is your nonprofit, add geographic service areas to create a map on your profile.

Login and update

Goals & Strategy

SOURCE: Self-reported by organization

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

The Toledo Community Oncology Program's aim is to expand cancer clinical trial availability and participation in the tri-state area, so all residents can receive the best available cancer care close to home, regardless of race, age, education level, or socioeconomic status.

A concerted outreach effort to educate oncologists, primary care and referring physicians, healthcare staff and administrators is needed to expand cancer clinical trial availability at more healthcare facilities in our service area. Raising community awareness of the benefits of clinical trials and educating people about clinical trial options before they or their loved one receive a devastating diagnosis is just as important. These two education and outreach initiatives will help ensure all of those touched by cancer benefit from the latest advances in cancer care.

The Toledo Community Oncology Program's Executive Director Pamela Shoup and Director of Development and Communications Deb Boyce are reaching out to healthcare facilities in the region. A newly formed Clinical Research Committee, led by TCOP’s Principal Investigator Rex Mowat, MD, and comprised of physician investigators from the University of Toledo Medical Center, and the region’s two largest healthcare providers, Mercy and ProMedica health systems, are working together to strategically expand cancer clinical trial availability, access, awareness, and accrual across the tri-state region.

The Toledo Community Oncology Program is one of the original 27 clinical research programs, fully-funded by the National Cancer Institute (NCI) since 1983, under the auspices of the National Institute for Health.

Nationally, TCOP is recognized for maintaining a strong record of clinical trial patient accrual and is considered to be one of the top accruing programs in the country by our research bases. Because TCOP offers Phase II, III, and IV clinical trials, participants are assured of receiving the best standard of cancer care available.

NCI grant funding is no longer sufficient to underwrite the need for cancer care in our 33-county, tri-state service area. New funding sources will expand the reach and impact of TCOP’s clinical trial program.

Financials

Toledo Community Hospital Oncology Program
lock

Unlock financial insights by subscribing to our monthly plan.

Subscribe

Unlock nonprofit financial insights that will help you make more informed decisions. Try our monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights?
Learn more about GuideStar Pro.

Operations

The people, governance practices, and partners that make the organization tick.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

Toledo Community Hospital Oncology Program

Board of directors
as of 06/05/2016
SOURCE: Self-reported by organization
Board chair

Dr. William Sternfeld

Toledo Community Oncology Program

Term: 2011 - 2014

William Horvath

Toledo Community Oncology Program

Mark Klopfenstein

Toledo Community Oncology Program

Darcel Shankle

Toledo Community Oncology Program

Rex Mowat

Toledo Clinic Cancer Centers

James Fugazzi

Toledo Radiation Oncologists

Board leadership practices

SOURCE: Self-reported by organization

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.

  • Board orientation and education
    Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? Yes
  • CEO oversight
    Has the board conducted a formal, written assessment of the chief executive within the past year ? Yes
  • Ethics and transparency
    Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? Yes
  • Board composition
    Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? Yes